Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TMX2-CTNND1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CREBZF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PAWR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZADH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKHD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
XPO4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPR180 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2C2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ALDH6A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CSAD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATXN7L3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLINT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMK2D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFYA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PBXIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FASTKD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on